Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$0.45 - $0.86 $13,197 - $25,221
-29,327 Reduced 11.95%
216,050 $112,000
Q3 2022

Nov 09, 2022

SELL
$0.46 - $0.63 $1,833 - $2,511
-3,986 Reduced 1.6%
245,377 $110,000
Q2 2022

Aug 11, 2022

SELL
$0.47 - $0.87 $2,218 - $4,106
-4,720 Reduced 1.86%
249,363 $145,000
Q1 2022

May 12, 2022

BUY
$0.75 - $1.77 $92,370 - $217,994
123,161 Added 94.07%
254,083 $200,000
Q4 2021

Feb 11, 2022

BUY
$1.56 - $2.93 $67,080 - $125,990
43,000 Added 48.91%
130,922 $212,000
Q3 2021

Nov 12, 2021

BUY
$2.91 - $4.83 $16,525 - $27,429
5,679 Added 6.91%
87,922 $264,000
Q2 2021

Aug 10, 2021

BUY
$4.17 - $5.74 $80,806 - $111,229
19,378 Added 30.82%
82,243 $384,000
Q1 2021

May 12, 2021

BUY
$5.28 - $9.64 $239,801 - $437,819
45,417 Added 260.3%
62,865 $332,000
Q4 2020

Feb 10, 2021

SELL
$5.75 - $7.13 $172,787 - $214,256
-30,050 Reduced 63.27%
17,448 $114,000
Q3 2020

Nov 12, 2020

BUY
$4.9 - $7.12 $164,444 - $238,947
33,560 Added 240.78%
47,498 $290,000
Q2 2020

Aug 13, 2020

SELL
$6.43 - $9.86 $261,726 - $401,341
-40,704 Reduced 74.49%
13,938 $101,000
Q1 2020

May 13, 2020

BUY
$6.36 - $10.05 $14,030 - $22,170
2,206 Added 4.21%
54,642 $380,000
Q4 2019

Feb 10, 2020

BUY
$8.49 - $12.81 $445,181 - $671,705
52,436 New
52,436 $462,000
Q2 2019

Aug 09, 2019

SELL
$5.22 - $9.08 $425,210 - $739,638
-81,458 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$5.35 - $9.82 $64,306 - $118,036
12,020 Added 17.31%
81,458 $641,000
Q4 2018

Feb 06, 2019

BUY
$3.43 - $6.19 $238,172 - $429,821
69,438 New
69,438 $344,000
Q3 2017

Nov 15, 2017

SELL
$15.1 - $19.25 $85,647 - $109,186
-5,672 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
5,672
5,672 $116,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.